Related references
Note: Only part of the references are listed.Regulation of Protein Tyrosine Phosphatase Oxidation in Cell Adhesion and Migration
Jeroen Frijhoff et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Novel in vitro cardiovascular constructs composed of vascular-like networks and cardiomyocytes
Hanna Vuorenpaa et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2014)
Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
Filipa S. Carvalho et al.
MEDICINAL RESEARCH REVIEWS (2014)
Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways
Jian Ma et al.
CARDIOVASCULAR RESEARCH (2013)
Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survival
Elizabeth M. Chislock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Role of ABL family kinases in cancer: from leukaemia to solid tumours
Emileigh K. Greuber et al.
NATURE REVIEWS CANCER (2013)
Glutathione/thioredoxin systems modulate mitochondrial H2O2 emission: An experimental-computational study
Miguel Antonio Aon et al.
JOURNAL OF GENERAL PHYSIOLOGY (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Cardiac-Specific Over-Expression of Epidermal Growth Factor Receptor 2 (ErbB2) Induces Pro-Survival Pathways and Hypertrophic Cardiomyopathy in Mice
Polina Sysa-Shah et al.
PLOS ONE (2012)
Mechanistic Investigation of Imatinib-Induced Cardiac Toxicity and the Involvement of c-Abl Kinase
Wenyue Hu et al.
TOXICOLOGICAL SCIENCES (2012)
Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs
F. Henjes et al.
ONCOGENESIS (2012)
Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death
Krishna K. Singh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
EPR detection of cellular and mitochondrial superoxide using cyclic hydroxylamines
Sergey I. Dikalov et al.
FREE RADICAL RESEARCH (2011)
The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro
Sarah J. Watkins et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2011)
Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2 Emission from Isolated Heart Mitochondria
Brian A. Stanley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Redox-optimized ROS balance: A unifying hypothesis
M. A. Aon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
c-Abl tyrosine kinase regulates cardiac growth and development
Zhaozhu Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro
Brian B. Hasinoff et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
How mitochondria produce reactive oxygen species
Michael P. Murphy
BIOCHEMICAL JOURNAL (2009)
Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets
Vilma A. Sardao et al.
CELL BIOLOGY AND TOXICOLOGY (2009)
Reciprocal regulation of Abl and receptor tyrosine kinases
Divyamani Srinivasan et al.
CELLULAR SIGNALLING (2009)
Mitochondria and reactive oxygen species
Alicia J. Kowaltowski et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation
Erich B. Tahara et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
Leo I. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Activation of Cu,Zn-Superoxide Dismutase in the Absence of Oxygen and the Copper Chaperone CCS
Jeffry M. Leitch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Comparison of two methods for assaying complex I activity in mitochondria isolated from rat liver, brain and heart
Jiangang Long et al.
LIFE SCIENCES (2009)
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Zachary T. Schafer et al.
NATURE (2009)
Glycogen Synthase Kinase 3 Inhibition Slows Mitochondrial Adenine Nucleotide Transport and Regulates Voltage-Dependent Anion Channel Phosphorylation
Samarjit Das et al.
CIRCULATION RESEARCH (2008)
Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts
Antoon J. M. Janssen et al.
CLINICAL CHEMISTRY (2007)
Heat shock protein 90 and Erb132 in the cardiac response to doxorubicin injury
Kathleen Gabrielson et al.
CANCER RESEARCH (2007)
Role of oxidative stress in cardiac hypertrophy and remodeling
Eiki Takimoto et al.
HYPERTENSION (2007)
Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes
Francesco Timolati et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Calcineurin activation is not necessary for doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: Involvement of the phosphoinositide 3-kinase-Akt pathway
Kevyn E. Merten et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor
Barbara Tanos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkela et al.
NATURE MEDICINE (2006)
Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells
Divyamani Srinivasan et al.
CANCER RESEARCH (2006)
Cardiotoxic effects of arsenic trioxide/imatinib mesilate combination in rats
SY Saad et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Hydrogen peroxide: A signaling messenger
James R. Stone et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Anti-erbB2 treatment induces cardiotoxicity by interfering with cell survival pathways
Thea Pugatsch et al.
BREAST CANCER RESEARCH (2006)
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31
E Tan-Chiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: Implications for uncoupling endothelial nitric oxide synthase
N Kuzkaya et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Expressional reprogramming of survival pathways in rat cardiocytes by neuregulin-1β
MN Giraud et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury
K Imahashi et al.
CIRCULATION RESEARCH (2004)
Inhibition of ErbB2 causes mitochondrial dysfunction in cardiornyocytes - Implications for herceptin-induced cardiomyopathy
LP Grazette et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1β/erbB4 signaling
Y Kuramochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors
J Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases
C Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Catalase activity is regulated by c-Abl and Arg in the oxidative stress response
C Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
C Özcelik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
ErbB2 is essential in the prevention of dilated cardiomyopathy
SA Crone et al.
NATURE MEDICINE (2002)
Overexpression of metallothionein reduces diabetic cardiomyopathy
QR Liang et al.
DIABETES (2002)
Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice
KL Gabrielson et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
The ErbB signaling network: receptor heterodimerization in development and cancer
MA Olayioye et al.
EMBO JOURNAL (2000)
Share Paper
